Real-world treatment (tx) patterns, cost, and overall survival (OS) by line of therapy among patients (pt) with mantle cell lymphoma (MCL): A SEER-Medicare (SM) analysis.
| Published in: | Journal of Clinical Oncology Vol. 40; pp. 19 - 20 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Journal Article |
| Published: |
American Society of Clinical Oncology
2022 Supplement 28
|
| Online Access: | View this record in EBSCOhost |